Related Experiment Video
Updated: May 7, 2026

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess
Published on: June 1, 2022
[Coenzyme q10 in complex therapy of patients with ischemic heart disease]
1Novosibirsk State Medical University, Krasny Prospect, 52, 630091 Novosibirsk, Russia.
Abstract:
The paper contains results of assessment of clinical efficacy and safety of coenzyme Q10 in patients with ischemic heart disease. Coenzyme Q10 (60 mg/day for 8 weeks) added to basic treatment of patients with stable class II-III angina significantly improved clinical status of these patients without clinically significant side effects.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Rheumatic Heart Disease III: Medical Management
Heart Failure Drugs: Inotropic Agents
Heart Failure VI: Adjunct Therapies
Rheumatic Heart Disease IV: Nursing Management
Cardiomyopathy VI: Nursing Management

